BR112013033007A2 - pharmaceutical composition for use against inflammation and pain - Google Patents
pharmaceutical composition for use against inflammation and painInfo
- Publication number
- BR112013033007A2 BR112013033007A2 BR112013033007A BR112013033007A BR112013033007A2 BR 112013033007 A2 BR112013033007 A2 BR 112013033007A2 BR 112013033007 A BR112013033007 A BR 112013033007A BR 112013033007 A BR112013033007 A BR 112013033007A BR 112013033007 A2 BR112013033007 A2 BR 112013033007A2
- Authority
- BR
- Brazil
- Prior art keywords
- pain
- pharmaceutical composition
- use against
- against inflammation
- inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2011006758A MX357376B (en) | 2011-06-22 | 2011-06-22 | Pharmaceutical composition for use against inflammation and pain. |
| PCT/IB2012/053157 WO2012176155A1 (en) | 2011-06-22 | 2012-06-21 | Pharmaceutical composition for use against inflammation and pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112013033007A2 true BR112013033007A2 (en) | 2017-01-31 |
Family
ID=47422093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112013033007A BR112013033007A2 (en) | 2011-06-22 | 2012-06-21 | pharmaceutical composition for use against inflammation and pain |
Country Status (13)
| Country | Link |
|---|---|
| AR (1) | AR086733A1 (en) |
| BR (1) | BR112013033007A2 (en) |
| CL (1) | CL2013003671A1 (en) |
| CO (1) | CO6831987A2 (en) |
| CR (1) | CR20130687A (en) |
| DO (1) | DOP2013000309A (en) |
| ES (1) | ES2441917B1 (en) |
| GT (1) | GT201300318A (en) |
| MX (1) | MX357376B (en) |
| NI (1) | NI201300142A (en) |
| PE (1) | PE20141530A1 (en) |
| RU (1) | RU2604149C2 (en) |
| WO (1) | WO2012176155A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2586607B1 (en) * | 2013-05-27 | 2017-07-20 | Farmacéuticos Rayere, S.A. | SYNERGISTIC PHARMACEUTICAL COMPOSITION OF TWO ANALGESICS WITH DIFFERENT PHARMACOCINETIC PROFILE |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1196307B (en) * | 1984-10-22 | 1988-11-16 | Chiesi Farma Spa | AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE |
| US5091182A (en) * | 1990-07-23 | 1992-02-25 | Syntex (U.S.A.) Inc. | Dispensing units for ketorolac topical gel formlations |
| US5436241A (en) * | 1994-01-14 | 1995-07-25 | Bristol-Myers Squibb Company | Topical anti-inflammatory compositions containing piroxicam |
| MXPA02010828A (en) * | 2002-11-04 | 2004-07-16 | Leopoldo Espinosa Abdala | Pharmaceutical composition in capsules comprising a non-steroidal anti-inflammatory and an opiate analgesic for handling pain. |
| RU2237470C1 (en) * | 2003-01-27 | 2004-10-10 | Купсин Евгений Вениаминович | Combined preparation for removing symptoms of catarrhal diseases and grippe (variants) |
| US8512727B2 (en) * | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
| MXPA04009698A (en) * | 2004-10-04 | 2006-04-05 | Maria Elena Garcia Armenta | Solid pharmaceutical formulations comprising diacereine and meloxicam. |
| WO2007148950A1 (en) * | 2006-06-20 | 2007-12-27 | Farmacéuticos Rayere, S.A. | Synergistic pharmaceutical composition of ketorolac and lysine clonixinate |
| MX2007003948A (en) * | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management. |
| US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
-
2011
- 2011-06-22 MX MX2011006758A patent/MX357376B/en active IP Right Grant
-
2012
- 2012-06-21 PE PE2013002871A patent/PE20141530A1/en not_active Application Discontinuation
- 2012-06-21 RU RU2013157013/15A patent/RU2604149C2/en active
- 2012-06-21 ES ES201390103A patent/ES2441917B1/en active Active
- 2012-06-21 WO PCT/IB2012/053157 patent/WO2012176155A1/en active Application Filing
- 2012-06-21 BR BR112013033007A patent/BR112013033007A2/en not_active Application Discontinuation
- 2012-06-22 AR ARP120102254A patent/AR086733A1/en not_active Application Discontinuation
-
2013
- 2013-12-20 GT GT201300318A patent/GT201300318A/en unknown
- 2013-12-20 CR CR20130687A patent/CR20130687A/en unknown
- 2013-12-20 NI NI201300142A patent/NI201300142A/en unknown
- 2013-12-20 DO DO2013000309A patent/DOP2013000309A/en unknown
- 2013-12-20 CO CO13297886A patent/CO6831987A2/en unknown
- 2013-12-20 CL CL2013003671A patent/CL2013003671A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2441917B1 (en) | 2014-11-25 |
| NI201300142A (en) | 2015-02-25 |
| WO2012176155A1 (en) | 2012-12-27 |
| CO6831987A2 (en) | 2014-01-10 |
| MX2011006758A (en) | 2013-01-10 |
| ES2441917A2 (en) | 2014-02-06 |
| DOP2013000309A (en) | 2014-04-15 |
| GT201300318A (en) | 2015-05-21 |
| MX357376B (en) | 2018-07-06 |
| CR20130687A (en) | 2014-02-21 |
| CL2013003671A1 (en) | 2014-07-11 |
| PE20141530A1 (en) | 2014-11-12 |
| AR086733A1 (en) | 2014-01-15 |
| RU2604149C2 (en) | 2016-12-10 |
| ES2441917R1 (en) | 2014-02-19 |
| RU2013157013A (en) | 2015-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012018947A2 (en) | pharmaceutical composition for cancer treatment and prevention | |
| CO6831975A2 (en) | Immunoconjugates, compositions to prepare them, methods to prepare them and use | |
| BR112013014583A2 (en) | pharmaceutical composition, and methods for treating inflammation, treating pain, and preparing 3-methanesulfonylpropionitrile | |
| BR112013033072A2 (en) | apoptosis inducing agent and pharmaceutical composition | |
| BR112013018877A2 (en) | pharmaceutical compositions comprising human antibodies to pcsk9 | |
| PL2908798T3 (en) | Strip for the delivery of an oral care active and methods for applying oral care actives | |
| BR112013029946A2 (en) | drug delivery device and method of controlling the device | |
| BR112014001255A2 (en) | compound use of a compound combination and pharmaceutical composition | |
| BR112012022878A2 (en) | compound, pharmaceutical composition, compound use and method of treatment | |
| BR112014005597A2 (en) | wound dressing composition and dressing | |
| BR112013030302A2 (en) | compound, pharmaceutical composition, use of a compound, combination of a compound and device | |
| BR112012014962A2 (en) | Methods and Compositions for Liquid and Stable Drug Formulations | |
| BR112013011448A2 (en) | compound, pharmaceutical composition, and use of compound | |
| BR112013014644A2 (en) | pharmaceutical composition and complex | |
| BR112013012476A2 (en) | pharmaceutical formulations containing corticosteroids for topical administration | |
| BR112014010739A2 (en) | therapeutic agents and their use | |
| BR112012031836A2 (en) | pharmaceutical combination for pain treatment | |
| BR112014013682A2 (en) | personal care composition | |
| BR112013011845A2 (en) | oral care product and methods of use and manufacture | |
| BR112015002706A2 (en) | Niclosamide and its derivatives for use in the treatment of solid tumors | |
| BR112012030927A2 (en) | fosfaplatins and their use for cancer treatment | |
| BR112013011562A2 (en) | oral care product and methods of use and manufacture | |
| BR112013015085A2 (en) | pharmaceutical composition, method for preparing a composition, and use of composition | |
| BR112013011852A2 (en) | oral care product and methods of use and manufacture | |
| SMT201500005B (en) | Inhalable pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |